Severe asthma: A focus on diagnosis risk assessment and costs
Oppenheimer, John

Comorbidities associated with severe asthma
Patel, Gayatri B.; Peters, Anju T.

Biomarkers in the context of managing severe asthma
Stanley J. Szefler, MD 

Targets in the use of biologics for asthma
John Oppenheimer, MD

Pearls and pitfalls in the diagnosis of cough variant asthma
William M. Corrao, MD

Assessing the unmet need for current and future biologics in pediatric asthma management*

Leonard Bacharier, MD

Pro/Con Debate:

PRO: Anti-IL5 therapies are biologics of choice for 

severe eosinophilic asthma*

Mario Castro, MD

CON: Anti-IL5 therapies are NOT biologics of choice for 

severe eosinophilic asthma*

Rey Panettieri, MD

Combinationics/beta-agonist inhaler as reliever therapy: 

FDA vs new guidelines*

Leonard Bacharier, MD

*Presented at the Eastern Allergy Conference, August 16-18, 2020